Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

医学 人口 随机化 射频消融术 肝细胞癌 临床终点 胃肠病学 核医学 外科 随机对照试验 烧蚀 内科学 环境卫生
作者
Tae Hyun Kim,Young Hwan Koh,Bo Hyun Kim,Min Ju Kim,Ju Hee Lee,Boram Park,Joong‐Won Park
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:74 (3): 603-612 被引量:152
标识
DOI:10.1016/j.jhep.2020.09.026
摘要

Proton beam radiotherapy (PBT) has recently been applied to treat hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based evidence on its safety and efficacy. We compared the outcomes of PBT and radiofrequency ablation (RFA) in patients with recurrent/residual HCC (rHCC) in a phase III non-inferiority trial.Patients with rHCC (size <3 cm, number ≤2) were randomly assigned to receive PBT or RFA according to Child-Pugh score and tumor stage. After randomization, if the assigned treatment was technically infeasible, crossover was allowed. The primary endpoint was 2-year local progression-free survival (LPFS), with a non-inferiority margin of 15% in the per-protocol (PP) population; a complementary analysis was performed in the intention-to-treat (ITT) population (NCT01963429).The ITT population comprised 144 patients receiving either PBT (n = 72) or RFA (n = 72). Six patients switched from the PBT arm to the RFA arm and 19 patients switched from the RFA arm to the PBT arm. In the PP population, the 2-year LPFS rate with PBT (n = 80) vs. RFA (n = 56) was 94.8% vs. 83.9%, a difference of 10.9 percentage points (90% CI 1.8-20.0; p <0.001); in the ITT population, the 2-year LPFS rate with PBT vs. RFA was 92.8% vs. 83.2%, a difference of 9.6 percentage points (90% CI 0.7-18.4; p <0.001), meeting the criteria for non-inferiority. The 3- and 4-year LPFS rates for PBT were also non-inferior to those for RFA. The most common adverse events were radiation pneumonitis (32.5%) and decreased leukocyte counts (23.8%) for PBT and increased alanine aminotransferase levels (96.4%) and abdominal pain (30.4%) for RFA. No Grade 4 adverse events or mortality were noted.PBT showed LPFS values that were non-inferior to those for RFA; in addition, PBT was tolerable and safe. CLINICAL TRIAL NUMBER: #NCT01963429 (ClinicalTrials.gov).Radiofrequency ablation is the standard of care for patients with small hepatocellular carcinoma in whom surgery is not feasible. This study is the first phase III randomized controlled trial to evaluate the clinical outcomes of proton beam radiotherapy vs. radiofrequency ablation in patients with recurrent small HCC. Our findings show that this new technique is not inferior and can be applied safely in patients with small recurrent hepatocellular carcinoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
懒羊羊完成签到,获得积分10
1秒前
1秒前
苏苏完成签到,获得积分10
1秒前
呆萌代桃发布了新的文献求助10
1秒前
dfgh完成签到,获得积分10
1秒前
飞云发布了新的文献求助10
1秒前
Aoia完成签到,获得积分10
1秒前
无昵称发布了新的文献求助10
2秒前
一一发布了新的文献求助10
3秒前
勾股定理发布了新的文献求助10
3秒前
SRJ完成签到,获得积分20
5秒前
5秒前
子衿发布了新的文献求助10
5秒前
meimale发布了新的文献求助10
6秒前
6秒前
Ava应助bbbjddd采纳,获得10
7秒前
7秒前
彭于彦祖应助DZQ采纳,获得30
7秒前
64658应助sh采纳,获得50
7秒前
May完成签到 ,获得积分20
8秒前
8秒前
8秒前
华仔应助Xxiao采纳,获得10
8秒前
8秒前
datang完成签到,获得积分10
9秒前
王鹏飞应助朝气采纳,获得10
9秒前
SRJ发布了新的文献求助30
10秒前
10秒前
mogugu完成签到,获得积分10
10秒前
山后别相逢完成签到 ,获得积分10
10秒前
11秒前
山鬼完成签到,获得积分10
11秒前
ZCM发布了新的文献求助10
11秒前
11秒前
搜集达人应助DXXX采纳,获得10
12秒前
李昆朋发布了新的文献求助10
12秒前
djbj2022发布了新的文献求助10
12秒前
Hayat应助跟我说晚安采纳,获得10
12秒前
隐形曼青应助糖醋可乐采纳,获得10
12秒前
大宝完成签到,获得积分10
13秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969322
求助须知:如何正确求助?哪些是违规求助? 3514152
关于积分的说明 11172188
捐赠科研通 3249407
什么是DOI,文献DOI怎么找? 1794832
邀请新用户注册赠送积分活动 875437
科研通“疑难数据库(出版商)”最低求助积分说明 804781